Skip to Main Content

Paper Details

Gene-set analysis based on the pharmacological profiles of drugs to identify repurposing opportunities in schizophrenia.
J Psychopharmacol
14
2016
Gene, PGC2, SCZ, dopamine, dopamine receptor, gene, gene sets, gene-sets, loci, metoclopramide, neratinib, schizophrenia, trifluoperazine, tyrosine, tyrosine kinase
Author NameAffiliation
Simone de JongInstitute of Psychiatry, King's College London, UK National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health
Younes MokrabSidra Medical Research Center
David A CollierInstitute of Psychiatry, King's College London, Eli Lilly and Company Ltd
David A CollierInstitute of Psychiatry, King's College London, Eli Lilly and Company Ltd
Gerome BreenInstitute of Psychiatry, King's College London, UK National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health
Gerome BreenInstitute of Psychiatry, King's College London, UK National Institute for Health Research (NIHR) Biomedical Research Centre for Mental Health
  • 1 - 6

Datasets

Release 1.2